BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17278048)

  • 1. Caspofungin in the treatment of symptomatic candiduria.
    Sobel JD; Bradshaw SK; Lipka CJ; Kartsonis NA
    Clin Infect Dis; 2007 Mar; 44(5):e46-9. PubMed ID: 17278048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
    Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
    Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin treatment and eradication of candiduria among hospitalized patients.
    Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
    Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature.
    Rezai MS; Vaezi A; Fakhim H; Soleimani A; Mohammad Jafari H; Mohseni S; Badali H
    J Mycol Med; 2017 Jun; 27(2):261-265. PubMed ID: 28188050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin for invasive candidiasis at a tertiary care medical center.
    Zaas AK; Dodds Ashley ES; Alexander BD; Johnson MD; Perfect JR
    Am J Med; 2006 Nov; 119(11):993.e1-6. PubMed ID: 17071169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida glabrata endophthalmitis treated successfully with caspofungin.
    Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
    Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin therapy of neonates with invasive candidiasis.
    Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
    Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
    Kartsonis N; Killar J; Mixson L; Hoe CM; Sable C; Bartizal K; Motyl M
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3616-23. PubMed ID: 16127030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of candida albicans mediastinitis after heart transplantation successfully treated with caspofungin.
    Garlicki M; Czub P; Filczak K; Wojdyga R; Puchniewicz M; Labuś K; Ehrlich MP
    Ann Transplant; 2006; 11(1):47-8. PubMed ID: 17025031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.
    Pelletier R; Alarie I; Lagacé R; Walsh TJ
    Med Mycol; 2005 Sep; 43(6):559-64. PubMed ID: 16320498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin.
    Dinubile MJ; Lupinacci RJ; Berman RS; Sable CA
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):903-8. PubMed ID: 12230933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.
    Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J
    J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin as treatment for Candida glabrata hip infection.
    Lejko-Zupanc T; Mozina E; Vrevc F
    Int J Antimicrob Agents; 2005 Mar; 25(3):273-4. PubMed ID: 15737527
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifungal resistance: the clinical front.
    Perfect JR
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
    Rajendram R; Alp NJ; Mitchell AR; Bowler IC; Forfar JC
    Clin Infect Dis; 2005 May; 40(9):e72-4. PubMed ID: 15825018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
    del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
    Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.